[Neoadjuvant therapy for renal cancer]

Prog Urol. 2008 Apr;18(4):256-8. doi: 10.1016/j.purol.2008.01.002. Epub 2008 May 2.
[Article in French]

Abstract

A 73-year-old man presented with renal cell carcinoma of the left kidney. Despite the absence of metastases, primary nephrectomy was not performed immediately due to the large tumour volume and the presence of large lymph node extension. The patient was treated with sunitinib for 10 months. Computed tomography at the end of treatment showed a significant reduction of the size of the tumour and the volume of lymph node extension. Radical nephrectomy was then performed. On histological evaluation, the primary renal tumour and, to a lesser degree, the lymph nodes were predominantly necrotic.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / diagnostic imaging
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / surgery
  • Chemotherapy, Adjuvant
  • Humans
  • Indoles / therapeutic use*
  • Kidney Neoplasms / diagnostic imaging
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / surgery
  • Lymph Node Excision
  • Male
  • Neoadjuvant Therapy / methods*
  • Nephrectomy
  • Pyrroles / therapeutic use*
  • Sunitinib
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Indoles
  • Pyrroles
  • Sunitinib